Pancreas Transplant Outcomes

At a Glance

• First transplant: 05/11/87
• Transplants performed in 2023: 3
• Total number of program transplants through 2023: 179
• Received Medicare approval: 07/01/99

Outcomes

• Pre-transplant mortality#: .034 (expected .028, national .364)
  

Adult one- and three-year patient survival rates for PAK (pancreas after kidney transplant)*:

• Henry Ford one-year patient survival rate: 100.00%
• Henry Ford one-year expected patient survival rate^: 97.72%
• Henry Ford three-year patient survival rate: 100.00%
• Henry Ford three-year expected patient survival rate^: 93.94%

Adult one- and three-year patient survival rates for PTA (pancreas transplant alone)*

• Henry Ford one-year patient survival rate: 100.00%
• Henry Ford one-year expected patient survival rate^: 98.31%
• Henry Ford three-year patient survival rate^: 100.00%
• Henry Ford three-year patient survival rate^: 94.81%

# Patients on the waitlist between 01/01/2022 and 12/31/2023
*Estimated probability of surviving at one year, for patients receiving their first transplant between 01/01/2021 and 6/30/2023; and at three years between for patients receiving their first transplant between 07/01/2018 – 3/12/2020 and 6/13/2020 – 12/31/2020
^ Adjusted for patient and donor characteristics

Source: Scientific Registry of Transplant Recipients, Center and OPO-specific Reports, based on data available April 30, 2024, released July 9, 2024.